Sign inGet started

McElhaugh Michael J.

Insider CIK 1635326 · ABUS Interim President & CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ABUS Arbutus Biopharma Corp A Award deriv2025-02-142025-02-19718,800— $0718,800SEC↗
ABUS Arbutus Biopharma Corp A Award2025-02-142025-02-19177,000— $01,658,003SEC↗
ABUS Arbutus Biopharma Corp S Sale2025-02-042025-02-0523,790$3.28 $78.0K1,481,003SEC↗
ABUS Arbutus Biopharma Corp S Sale2024-02-022024-02-0510,164$2.31 $23.5K1,504,793SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2024-02-012024-02-05495,100— $0495,100SEC↗
ABUS Arbutus Biopharma Corp A Award2024-02-012024-02-05123,800— $01,514,957SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2023-02-012023-02-03334,700— $0334,700SEC↗
ABUS Arbutus Biopharma Corp A Award2023-02-012023-02-0383,700— $01,391,157SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2022-01-202022-01-20325,850$2.81 $915.6K325,850SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2021-02-132021-02-17249,000— $0249,000SEC↗
ABUS Arbutus Biopharma Corp S Sale2021-02-092021-02-1020,000$5.00 $100.0K1,307,457SEC↗
ABUS Arbutus Biopharma Corp S Sale2020-12-142020-12-1630,000$5.00 $150.0K1,337,457SEC↗
ABUS Arbutus Biopharma Corp S Sale2020-12-142020-12-1610,000$5.00 $50.0K1,327,457SEC↗
ABUS Arbutus Biopharma Corp S Sale2020-07-232020-07-2720,000$5.01 $100.2K1,367,457SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2020-02-172020-02-19200,000— $0200,000SEC↗
ABUS Arbutus Biopharma Corp A Award deriv2019-03-012019-03-05104,500— $0104,500SEC↗